GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » Equity-to-Asset

Sirona Biochem (TSXV:SBM) Equity-to-Asset : -3.98 (As of Jan. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sirona Biochem's Total Stockholders Equity for the quarter that ended in Jan. 2024 was C$-2.79 Mil. Sirona Biochem's Total Assets for the quarter that ended in Jan. 2024 was C$0.70 Mil. Therefore, Sirona Biochem's Equity to Asset Ratio for the quarter that ended in Jan. 2024 was -3.98.

The historical rank and industry rank for Sirona Biochem's Equity-to-Asset or its related term are showing as below:

TSXV:SBM' s Equity-to-Asset Range Over the Past 10 Years
Min: -5.87   Med: 0.15   Max: 0.64
Current: -3.98

During the past 13 years, the highest Equity to Asset Ratio of Sirona Biochem was 0.64. The lowest was -5.87. And the median was 0.15.

TSXV:SBM's Equity-to-Asset is ranked worse than
96.23% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs TSXV:SBM: -3.98

Sirona Biochem Equity-to-Asset Historical Data

The historical data trend for Sirona Biochem's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Equity-to-Asset Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.02 -0.08 0.17 -2.43

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.46 -0.59 -1.20 -2.43 -3.98

Competitive Comparison of Sirona Biochem's Equity-to-Asset

For the Biotechnology subindustry, Sirona Biochem's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's Equity-to-Asset falls into.



Sirona Biochem Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sirona Biochem's Equity to Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Equity to Asset (A: Oct. 2023 )=Total Stockholders Equity/Total Assets
=-2.511/1.032
=-2.43

Sirona Biochem's Equity to Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

Equity to Asset (Q: Jan. 2024 )=Total Stockholders Equity/Total Assets
=-2.792/0.701
=-3.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem  (TSXV:SBM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sirona Biochem Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (TSXV:SBM) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (TSXV:SBM) Headlines